Cargando…

Organoid models of fibrolamellar carcinoma mutations reveal hepatocyte transdifferentiation through cooperative BAP1 and PRKAR2A loss

Fibrolamellar carcinoma (FLC) is a lethal primary liver cancer, affecting young patients in absence of chronic liver disease. Molecular understanding of FLC tumorigenesis is limited, partly due to the scarcity of experimental models. Here, we CRISPR-engineer human hepatocyte organoids to recreate di...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rüland, Laura, Andreatta, Francesco, Massalini, Simone, Chuva de Sousa Lopes, Susana, Clevers, Hans, Hendriks, Delilah, Artegiani, Benedetta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10156813/ https://www.ncbi.nlm.nih.gov/pubmed/37137901 http://dx.doi.org/10.1038/s41467-023-37951-6

Ejemplares similares

Engineered human hepatocyte organoids enable CRISPR-based target discovery and drug screening for steatosis
por: Hendriks, Delilah, et al.
Publicado: (2023)

Temporal morphogen gradient-driven neural induction shapes single expanded neuroepithelium brain organoids with enhanced cortical identity
por: Pagliaro, Anna, et al.
Publicado: (2023)

Development of Plasmodium falciparum liver-stages in hepatocytes derived from human fetal liver organoid cultures
por: Yang, Annie S. P., et al.
Publicado: (2023)

Editorial: Mechanisms of cellular differentiation, organ development, and novel model systems
por: Hendriks, Delilah, et al.
Publicado: (2022)

Human liver organoids for disease modeling of fibrolamellar carcinoma
por: Narayan, Nicole J.C., et al.
Publicado: (2022)

A comprehensive transcriptomic comparison of hepatocyte model systems improves selection of models for experimental use
por: Ardisasmita, Arif Ibrahim, et al.
Publicado: (2022)

One-step generation of tumor models by base editor multiplexing in adult stem cell-derived organoids
por: Geurts, Maarten H., et al.
Publicado: (2023)

PRKAR1A and Thyroid Tumors
por: Pitsava, Georgia, et al.
Publicado: (2021)

Fibrolamellar Carcinoma: 2012 Update
por: Torbenson, Michael
Publicado: (2012)

Mixed fibrolamellar hepatocellular carcinoma
por: Limaiem, Faten, et al.
Publicado: (2021)

Modeling Cryptosporidium infection in human small intestinal and lung organoids
por: Heo, Inha, et al.
Publicado: (2018)

MicroRNA-22 Can Reduce Parathymosin Expression in Transdifferentiated Hepatocytes
por: Chen, Hung-Lin, et al.
Publicado: (2012)

The role of insulin in transdifferentiated hepatocyte proliferation and function in serum‐free medium
por: Gu, Ce, et al.
Publicado: (2019)

IL‐8 induces transdifferentiation of mature hepatocytes toward the cholangiocyte phenotype
por: Sasaki, Tokio, et al.
Publicado: (2019)

To BaP or not to BaP? That is the question.
por: Goldstein, L S
Publicado: (2001)

Novel Mutation in PRKAR1A in Carney Complex
por: Park, Ko Un, et al.
Publicado: (2012)

Hematopoietic neoplasms in Prkar2a-deficient mice
por: Saloustros, Emmanouil, et al.
Publicado: (2015)

Mutant ASXL1 cooperates with BAP1 to promote myeloid leukaemogenesis
por: Asada, Shuhei, et al.
Publicado: (2018)

Fibrolamellar Carcinomas are Positive for CD68
por: Ross, Hillary M, et al.
Publicado: (2010)

Radiotherapy for Metastatic Fibrolamellar Hepatocellular Carcinoma
por: G. Peacock, Justin, et al.
Publicado: (2013)

Metastatic Fibrolamellar Hepatocellular Carcinoma to the Pancreas
por: Villa, Nicolas A., et al.
Publicado: (2015)

De novo formation of the biliary system by TGFβ-mediated hepatocyte transdifferentiation
por: Schaub, Johanna R., et al.
Publicado: (2018)

Expression of hepatocytic- and biliary-specific transcription factors in regenerating bile ducts during hepatocyte-to-biliary epithelial cell transdifferentiation
por: Limaye, Pallavi B, et al.
Publicado: (2010)

Nanoblades allow high-level genome editing in murine and human organoids
por: Tiroille, Victor, et al.
Publicado: (2023)

Infrequent chromosome allele loss in fibrolamellar carcinoma.
por: Ding, S. F., et al.
Publicado: (1993)

Mitochondrial Mutations in Hepatocellular Carcinomas and Fibrolamellar Carcinomas
por: Vivekanandan, Perumal, et al.
Publicado: (2010)

Surgical Resection of Ruptured Fibrolamellar Hepatocellular Carcinoma
por: Minutolo, Vincenzo, et al.
Publicado: (2013)

Synchronous Fibrolamellar Hepatocellular Carcinoma and Auricular Myxoma
por: González-Cantú, Yessica M., et al.
Publicado: (2015)

Fibrolamellar hepatocellular carcinoma: current clinical perspectives
por: Lafaro, Kelly J, et al.
Publicado: (2015)

Molecular testing for the clinical diagnosis of fibrolamellar carcinoma
por: Graham, Rondell P, et al.
Publicado: (2018)

Fibrolamellar Hepatocellular Carcinoma and Noncirrhotic Hyperammonemic Encephalopathy
por: Suarez, Oscar, et al.
Publicado: (2018)

Spontaneous Rupture of Fibrolamellar Variant Hepatocellular Carcinoma
por: Polavarapu, Abhishek D., et al.
Publicado: (2019)

Immunohistochemical detection of procalcitonin in fibrolamellar hepatocellular carcinoma
por: Matsumoto, Kotaro, et al.
Publicado: (2021)

Targeting BCL-XL in fibrolamellar hepatocellular carcinoma
por: Shebl, Bassem, et al.
Publicado: (2022)

Current Advances in the Treatment of Fibrolamellar Carcinoma of Liver
por: Gummadi, Jyotsna, et al.
Publicado: (2023)

COVID-19: organoids go viral
por: Clevers, Hans
Publicado: (2020)

Recurrent somatic mutations of PRKAR1A in isolated cardiac myxoma
por: He, Jian, et al.
Publicado: (2017)

PRKAR1A deficiency impedes hypertrophy and reduces heart size
por: Liu, Yuening, et al.
Publicado: (2020)

STK25 inhibits PKA signaling by phosphorylating PRKAR1A
por: Zhang, Xiaokan, et al.
Publicado: (2022)

An Efficient and Footprint-Free Protocol for the Transdifferentiation of Hepatocytes Into Insulin-Producing Cells With IVT mRNAs
por: Ma, Shinan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_j6bj4jvt9bo6aaa76o6g4u6tvs